A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer

BACKGROUND: FOLFIRINOX is a pillar first-line regimen in the treatment of pancreatic cancer. Historically, biliary tract cancer (BTC) and pancreatic cancer have been treated similarly with gemcitabine alone or combined with a platinum compound. With growing evidence supporting the role of fluoropyri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulusakarya, Ayhan, Karaboué, Abdoulaye, Ciacio, Oriana, Pittau, Gabriella, Haydar, Mazen, Biondani, Pamela, Gumus, Yusuf, Chebib, Amale, Almohamad, Wathek, Innominato, Pasquale F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268699/
https://www.ncbi.nlm.nih.gov/pubmed/32493242
http://dx.doi.org/10.1186/s12885-020-07004-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268699/
https://www.ncbi.nlm.nih.gov/pubmed/32493242
http://dx.doi.org/10.1186/s12885-020-07004-y

Ejemplares similares